AT379816B - Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit - Google Patents

Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit

Info

Publication number
AT379816B
AT379816B AT0307081A AT307081A AT379816B AT 379816 B AT379816 B AT 379816B AT 0307081 A AT0307081 A AT 0307081A AT 307081 A AT307081 A AT 307081A AT 379816 B AT379816 B AT 379816B
Authority
AT
Austria
Prior art keywords
producing new
new steroids
inflammatory effectiveness
inflammatory
effectiveness
Prior art date
Application number
AT0307081A
Other languages
English (en)
Other versions
ATA307081A (de
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Priority to AT265684A priority Critical patent/AT379817B/de
Publication of ATA307081A publication Critical patent/ATA307081A/de
Application granted granted Critical
Publication of AT379816B publication Critical patent/AT379816B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0307081A 1980-07-10 1981-07-10 Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit AT379816B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT265684A AT379817B (de) 1980-07-10 1984-08-20 Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16845380A 1980-07-10 1980-07-10
US26578581A 1981-05-21 1981-05-21

Publications (2)

Publication Number Publication Date
ATA307081A ATA307081A (de) 1985-07-15
AT379816B true AT379816B (de) 1986-03-10

Family

ID=26864131

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0307081A AT379816B (de) 1980-07-10 1981-07-10 Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit

Country Status (17)

Country Link
KR (2) KR860000266B1 (de)
AT (1) AT379816B (de)
AU (1) AU540898B2 (de)
CA (1) CA1174667A (de)
CH (1) CH648856A5 (de)
DE (1) DE3126732C2 (de)
DK (1) DK165837C (de)
ES (2) ES504340A0 (de)
FI (1) FI71748C (de)
FR (1) FR2486529A1 (de)
GB (1) GB2079755B (de)
IT (1) IT1205446B (de)
NL (1) NL192343C (de)
NO (1) NO163285C (de)
PH (1) PH25874A (de)
PT (1) PT73348B (de)
SE (1) SE449106B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
JPS6041607A (ja) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd 軟膏基剤
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
DE3786174T2 (de) * 1987-10-13 1993-10-21 Nicholas S Bodor Weiche steroide mit anti-entzündungswirkung.
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
JP2000513380A (ja) * 1997-06-30 2000-10-10 グラクソ、グループ、リミテッド 化合物
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
PT2348032E (pt) 2000-08-05 2015-10-14 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-'(2-furanilcarboxil)oxi]-11.beta.-hidroxi-16.alfa.- metil-3-oxo-androsta-1,4-dieno-17-carbotióico como um agente anti-inflamatório
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
WO2006072599A2 (en) 2005-01-10 2006-07-13 Glaxo Group Limited Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
CN101942001B (zh) * 2010-08-24 2013-02-06 山东省医药工业研究所 一种氯替泼诺的提纯方法
CN103183714A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种氯替泼诺的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
IT1114534B (it) * 1978-02-08 1986-01-27 Glaxo Group Ltd Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK302181A (da) 1982-01-11
NL192343B (nl) 1997-02-03
SE449106B (sv) 1987-04-06
FR2486529A1 (fr) 1982-01-15
ES8300785A1 (es) 1982-12-01
GB2079755A (en) 1982-01-27
GB2079755B (en) 1985-01-30
DE3126732C2 (de) 1987-04-30
IT8105186A0 (it) 1981-07-09
KR860000266B1 (ko) 1986-03-22
AU540898B2 (en) 1984-12-06
NL192343C (nl) 1997-06-04
SE8104132L (sv) 1982-01-11
ES504340A0 (es) 1982-12-01
ES514633A0 (es) 1983-06-16
CH648856A5 (de) 1985-04-15
PT73348B (en) 1982-09-23
FI71748C (fi) 1987-02-09
KR830006327A (ko) 1983-09-24
FI71748B (fi) 1986-10-31
IT1205446B (it) 1989-03-23
NO163285C (no) 1990-05-02
NO812344L (no) 1982-01-11
ATA307081A (de) 1985-07-15
KR850002759A (ko) 1985-05-15
DE3126732A1 (de) 1982-03-25
FI812175L (fi) 1982-01-11
NO163285B (no) 1990-01-22
FR2486529B1 (de) 1985-01-04
CA1174667A (en) 1984-09-18
DK165837B (da) 1993-01-25
ES8306767A1 (es) 1983-06-16
KR860000452B1 (ko) 1986-04-26
PH25874A (en) 1991-12-02
NL8103315A (nl) 1982-02-01
PT73348A (en) 1981-08-01
AU7259181A (en) 1982-01-14
DK165837C (da) 1993-06-21

Similar Documents

Publication Publication Date Title
AT379816B (de) Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT378962B (de) Verfahren zur herstellung von neuen cephalosporinen
AT385510B (de) Verfahren zur herstellung von neuen 10-alkinylsteroiden
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
ATA138979A (de) Verfahren zur herstellung von neuen steroiden
AT383125B (de) Verfahren zur herstellung von neuen mutterkornalkaloiden
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
ATA232880A (de) Verfahren zur herstellung von neuen steroidverbindungen
AT382874B (de) Verfahren zur herstellung von neuen mutterkornalkaloiden
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
AT379817B (de) Verfahren zur herstellung von neuen steroiden mit entzuendungshemmender wirksamkeit
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten
AT382382B (de) Verfahren zur herstellung von neuen kortikoiden
AT373900B (de) Verfahren zur herstellung von neuen kortikoiden
AT373899B (de) Verfahren zur herstellung von neuen kortikoiden
AT373898B (de) Verfahren zur herstellung von neuen kortikoiden

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELA Expired due to lapse of time